Natalie C. Holles - 11 Aug 2025 Form 4 Insider Report for Third Harmonic Bio, Inc. (THRD)

Role
CEO, Director
Signature
/s/ Natalie Holles
Issuer symbol
THRD
Transactions as of
11 Aug 2025
Net transactions value
$0
Form type
4
Filing time
14 Aug 2025, 16:09:05 UTC
Previous filing
04 Jun 2025
Next filing
07 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Holles Natalie C. CEO, Director C/O THIRD HARMONIC BIO, INC., 1700 MONTGOMERY STREET, SUITE 210, SAN FRANCISCO /s/ Natalie Holles 14 Aug 2025 0001580111

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction THRD Common Stock Other -1,218,836 -100% 0 11 Aug 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction THRD Stock Option Other $0 -998,854 -100% $0.000000 0 11 Aug 2025 Common Stock 998,854 Direct F1, F3
transaction THRD Restricted Stock Unit Other $0 -50,000 -100% $0.000000 0 11 Aug 2025 Common Stock 50,000 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction reported is a cancellation of shares of common stock in connection with the dissolution of the Issuer.
F2 The reporting person received a liquidation distribution of $5.35 per share of Common Stock from Issuer.
F3 Represents payment of the liquidation distribution of $5.35 per share less the exercise price of such options.
F4 The restricted stock units were deemed vested aod settled on the date of the liquidation distribution, and such settled shares received a liquidation distribution of $5.35 per share.